The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.
about
AID and APOBECs span the gap between innate and adaptive immunityThe genetic architecture of adaptations to high altitude in EthiopiaHuman LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activityExosomes in Human Immunodeficiency Virus Type I Pathogenesis: Threat or Opportunity?Suppression of APOBEC3-mediated restriction of HIV-1 by VifAPOBEC3 Interference during Replication of Viral GenomesSpecific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV TargetMov10 suppresses retroelements and regulates neuronal development and function in the developing brain.R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced From Latently Infected CellsDifferent modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.Immunogenetics of small ruminant lentiviral infectionsVif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.Human semen contains exosomes with potent anti-HIV-1 activity.Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase.Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase proteinAntiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family.Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophagesRunning loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinCreation of chimeric human/rabbit APOBEC1 with HIV-1 restriction and DNA mutation activities.Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.Binding of RNA by APOBEC3G controls deamination-independent restriction of retrovirusesAPOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular MechanismsOligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.APOBECs and virus restriction.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins.CBFß and HIV Infection.The role of cytidine deaminases on innate immune responses against human viral infections.Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G.Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
P2860
Q21131084-205F1075-E101-44C8-9D55-2508A7CF9D56Q21563365-C171B7E8-C829-479F-ADCD-2E2AEEA25EFFQ24625056-F81627D6-3A07-45D9-A2CC-50428F358D31Q26765283-1DF93A12-2721-4C1B-AFF2-B72AF090075EQ27025150-C9BD789B-084B-48CC-9F5F-5825B8734F88Q28081195-C1C9AF27-D56A-40EE-875B-14D0790B7317Q28551203-D9B0509E-7236-44A1-9C3A-BF22FD0856BEQ32174293-CA8E5A21-AE60-44D1-BC32-DC97C3F27BAAQ33637221-C05AFB10-594A-4269-B704-7F5D5102252FQ33650603-A9E0A311-06FF-41ED-BB2D-0D16030EA158Q34434913-41C50518-1367-47A4-80FB-F2CCE52C6E08Q34539110-B9623BEB-8CFC-4972-9361-E2EA8E3A8DB4Q34578814-905E3AC2-1920-4B33-BD2F-4548C0F3852EQ34745411-82D7E422-4770-42DB-8E6B-A631311AB287Q35068754-FBE3B85A-10FA-4755-9856-02186A76B915Q35487739-ED2A41DE-B432-4171-9DA5-C3A3159A9226Q36081987-21CAB0E9-2747-4182-9326-85BD3FCA2B26Q36156679-9FCA6FE7-BE8F-4A32-A1A3-0DC4B0A6E46CQ36299884-7BDAD854-1BF4-4016-9277-C31E4729D4AFQ36432758-E7DB3D85-CA5A-458B-8B24-5183D50B096FQ36438515-80A794C5-4CDD-4BCA-82AC-A255803B7073Q36559921-26D696DF-7687-4E2D-841A-561448EED2DCQ36895829-32342285-5C39-4AED-820F-E2B861658945Q37059673-7DCB49A7-7AA1-459C-9F10-2C150430D757Q37122122-6A47F7E6-EFDD-40E7-AFC2-1CC57B0DDE09Q37512973-2B95CC13-FDA1-4C01-83E9-2141CF8120FEQ37631430-3EDE5F2B-E6A5-4695-B705-D12734737586Q37739072-FD58D750-C92D-444F-AD46-B8AA7298CDBAQ38269459-B6010A65-8C21-4D06-9BD2-8BF1DAD03E2CQ38394187-DDC882A6-967F-4240-9543-1EF53DDAA446Q38524164-3EE05A14-8CDD-4565-B079-06B9453927ABQ38613375-89AC7AEA-58E9-4DEF-9004-B2FB3F983D6BQ38746224-6DDA51F0-9957-4812-BC08-F19B806E5A81Q38928610-559B5DD3-955B-44CB-B18C-1067EE30C8E8Q39181425-79ECE5B7-4E83-4EB6-90D8-57233B444D5AQ41812539-B512E7ED-F600-4151-B537-91871916D4F0Q47380909-1913D162-19C9-40D4-B6D6-F1C6773A3864Q54237606-40A6A724-4BED-46AB-82AD-C330A38D238A
P2860
The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The cellular antiviral protein ...... tion during viral replication.
@en
The cellular antiviral protein ...... tion during viral replication.
@nl
type
label
The cellular antiviral protein ...... tion during viral replication.
@en
The cellular antiviral protein ...... tion during viral replication.
@nl
prefLabel
The cellular antiviral protein ...... tion during viral replication.
@en
The cellular antiviral protein ...... tion during viral replication.
@nl
P2093
P2860
P356
P1433
P1476
The cellular antiviral protein ...... tion during viral replication.
@en
P2093
Jinyu Peng
Xiaojian Yao
Xiaoxia Wang
P2860
P304
P356
10.1128/JVI.06594-11
P407
P577
2012-02-01T00:00:00Z